Clinical Trial Update: Platelet PAR-1 Activation in Health and Diabetes

View source ↗

Summary

A completed clinical trial investigated platelet PAR-1 activation in individuals with Type 2 diabetes mellitus and in healthy controls.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Type 2 Diabetes, Healthy | Status: COMPLETED